X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

期刊標題檢索 J CANCER RES CL 最新評論: On April 9th, the editor stated that the images were not clear and re... (2025-04-09)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY]您好,您是該頁面的第 243125 位訪客。

期刊簡介
期刊名稱JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
LetPub Score
6.8
50 ratings
Rate

Reputation
7.5

Influence
5.7

Speed
9.4

期刊簡稱J CANCER RES CLIN
ISSN0171-5216
E-ISSN1432-1335
h-index87
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.001.0230.953
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q3207 / 404
Category: Medicine
Subcategory: Cancer Research
Q3154 / 230

自引率 (2023-2024)3.70%自引率趨勢
掲載範囲
The "Journal of Cancer Research and Clinical Oncology" publishes significant and up-to-date articles within the fields of experimental and clinical oncology. The journal, which is chiefly devoted to Original papers, also includes Reviews as well as Editorials and Guest editorials on current, controversial topics. The section Letters to the editors provides a forum for a rapid exchange of comments and information concerning previously published papers and topics of current interest. Meeting reports provide current information on the latest results presented at important congresses.

The following fields are covered: carcinogenesis - etiology, mechanisms; molecular biology; recent developments in tumor therapy; general diagnosis; laboratory diagnosis; diagnostic and experimental pathology; oncologic surgery; and epidemiology.
官方網站https://www.springer.com/432
在線稿件提交https://www.editorialmanager.com/jocr/
開放訪問No
出版商Springer Berlin Heidelberg
主題領域医学
出版國/地區GERMANY
發行頻率月刊
創刊年1904
每年文章數969每年文章數趨勢
黃金OA百分比35.12%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ3163/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0171-5216%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
競爭力 *來自作者的數據: About 54.16%
參考鏈接
相關期刊 【JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    Asian Pacific Journal of Cancer Prevention380815
    CANCER LETTERS356158
    CANCER RESEARCH332370
    BMC CANCER286136
    INTERNATIONAL JOURNAL OF CANCER225908
    ONCOLOGY REPORTS207866
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH200169
    CLINICAL CANCER RESEARCH194386
    CA-A CANCER JOURNAL FOR CLINICIANS168044
    CANCER149599
  •  

    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/79)
  [JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY] 的評論撰寫評論
作者: 机智的小明


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-04-09 11:09:40 評論於
On April 9th, the editor stated that the images were not clear and requested a resubmission. The initially submitted images were high-resolution and placed in a Word document, but the editor mentioned that they were not clear and below 300dpi. It is unclear why this happened. The images were resubmitted separately in a Word document with only text. Nonetheless, the response was quite prompt.
(0) 讚! | 机智的小明

作者: 机智的小明


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-04-09 11:05:46 評論於
April 9th record: The editor mentioned that the pictures are not clear and requested for them to be modified and resubmitted. The initial submission had high-resolution images placed in Word, but the editor stated that they were not clear enough and must be at least 300dpi. The reason for this is unknown. The images were resubmitted separately in Word, with only text included.
(0) 讚! | 机智的小明

作者: ccdoct


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-04-08 23:02:58 評論於
At what stage is your investment now?
(0) 讚! | ccdoct

作者: 机智的小明


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-04-07 23:07:29 評論於
The article I wrote has been rejected all the way. I submitted it to this magazine on April 7, 2025, just keeping a record. Hopefully there will be a good outcome.
(0) 讚! | 机智的小明

作者: ccdoct


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-03-25 18:28:17 評論於
How are you doing? How long does peer review take?
(0) 讚! | ccdoct

作者: ccdoct


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-03-23 17:51:20 評論於
How long does it take for the editors to be assigned after submitting the tumor bioinformatics analysis paper? I am in a hurry to graduate.
(0) 讚! | ccdoct

作者: Melatonine


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-03-22 13:43:22 評論於
Can anyone tell me how fast this magazine is? The official website says the first review decision will be made in 2 days, but it has been a week for me. Is this normal? I am in a hurry to graduate (crying).
(3) 讚! | Melatonine

作者: scikiller


領域: 医学
審稿時間: 5.0 month(s)
結果: 待定&不明


撰寫評論

2025-03-20 08:16:08 評論於
The corrupt journal finally got shut down, it's a relief for everyone.
(1) 讚! | scikiller

作者: hasuhasu


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-12-09 19:21:26 評論於
Original: 楼主,你的送审了吗?我的也with editor 一周了
Translation: OP, has yours been submitted for review? Mine has also been with the editor for a week.
(0) 讚! | hasuhasu

作者: 投稿必中


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2024-12-04 21:25:44 評論於
Found it, need to go to the official website of the magazine and register for the submission link called "Spring Nature", then you can submit your manuscript.
(0) 讚! | 投稿必中

作者: 投稿必中


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2024-12-04 21:22:57 評論於
I also don't know where to submit the contributions. Can you please tell me?
(0) 讚! | 投稿必中

作者: 投稿必中


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-12-04 21:20:37 評論於
I have also encountered such a problem, how should I submit the magazine? Has the original poster solved it?
(0) 讚! | 投稿必中

作者: 嗨哈哈


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2024-11-27 13:40:50 評論於
The review process was very quick, and we received feedback from a reviewer. Shortly after, the paper was rejected.
(0) 讚! | 嗨哈哈

作者: 嗨哈哈


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-14 21:08:26 評論於
Is this magazine non-OA? How come the official website shows that it became OA after January 24th? Am I mistaken?

Help!!! Also, why can't I find the submission section? It keeps showing an error. Can anyone help me with this? Please let me know.
(0) 讚! | 嗨哈哈

作者: pupuhaha


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-14 13:14:22 評論於
Accepted, a very reliable journal with responsible editors and a fast review process.
(0) 讚! | pupuhaha

作者: pupuhaha


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-06 09:42:17 評論於
The editors and reviewers of the 11-2 overhaul are very professional, providing many detailed suggestions without being overly critical. One of the reviewers has shown approval, and the revisions will continue to be updated.
(0) 讚! | pupuhaha

作者: Uranium


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-03 07:21:52 評論於
? 2024-11-3 directly rejected, no objections.
(0) 讚! | Uranium

作者: pupuhaha


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-31 23:12:45 評論於
I also submitted on 2024-10-15, with peer review on the 18th. 10 reviewers were invited, and one accepted on the same day. By the 23rd, one reviewer's feedback was received, and two more reviewers accepted. Currently waiting for the next steps.
(0) 讚! | pupuhaha

作者: 龙鳞映雪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-30 14:06:40 評論於
I am also preparing to submit to this journal now. May I ask if you upload images and text in the same Word document? Will the images be inserted throughout the text or placed at the end of the article?
(0) 讚! | 龙鳞映雪

作者: Dezhen Chen


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-23 16:19:37 評論於
Submitted on October 15, 2024, peer reviewed on October 23, 2024, rejected on October 30.
(1) 讚! | Dezhen Chen

作者: luciaa


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-10-21 10:13:44 評論於
Invited 10+ reviewers, 2 reviewers accepted the invitation 3-4 days later. They provided detailed comments, and the revisions were quickly accepted. Now it's fully OA, but the APC is relatively expensive. I'm wondering how long it takes for family members to receive the proof after accepting the invitation??? Haven't heard anything recently!!
(0) 讚! | luciaa

作者: Uranium


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-20 15:54:30 評論於
?2024-10-20 peer review

Please translate the above sentence into English: ?2024-10-20 peer review
(0) 讚! | Uranium

作者: Uranium


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-17 08:26:19 評論於
Submitted on October 16, 2024, to keep a record.
(0) 讚! | Uranium

作者: Dezhen Chen


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-15 14:40:17 評論於
Submitted on 2024-10-15, just documenting.
(0) 讚! | Dezhen Chen

作者: dave-1


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-14 11:04:29 評論於
The submission results for October 13 are unknown, just making a note of it.
(0) 讚! | dave-1

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/79)

開始撰寫 [JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*